LIVE
Research blend combining Retatrutide (triple agonist at GLP-1, GIP, and glucagon receptors) with Cagrilintide (long-acting amylin analog). Explores multi-target metabolic research where incretin and amylin pathways are engaged together.
For research purposes only. Not medical advice.
Glacier Aminos currently lists Retatrutide + Cagrilintide Blend at $5.46/mg, the lowest indexed price across 5 tracked research peptide vendors.
Retatrutide + Cagrilintide Blend ranges from $3.31/mg to $7.87/mg across 6 listings from 5 research peptide vendors, normalized to USD per milligram and refreshed daily.
5 research peptide vendors currently list Retatrutide + Cagrilintide Blend on PeptideScouter, with 3 in stock right now. We track 6 active listings across size and kit variants.
